NCT06255418

Brief Summary

The goal of this observational study is to define the incidence of heart failure (HF) after acute coronary syndrome (ACS). The main question it aims to answer is: • To define HF incidence in the medium and long-term in the context of public healthcare coverage ensuring universal access to early coronary revascularization after ACS and extended neurohormonal treatment. Analyses will cover the entire population of Catalonia (North-Eastern region of Spain, N = 7.860.563 in 2020). Researchers will compare HF incidence rate according to relevant subgroup characteristics including event type, age groups or sex, inter alia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,860,560

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 4, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 13, 2024

Completed
Last Updated

February 16, 2024

Status Verified

February 1, 2024

Enrollment Period

10 years

First QC Date

February 4, 2024

Last Update Submit

February 15, 2024

Conditions

Keywords

heart failureacute coronary syndromereal-world evidencehealthcare resources consumptionlong-term heart failurebig data

Outcome Measures

Primary Outcomes (2)

  • Baseline characteristics

    The first co-primary outcome is to define the baseline characteristics of the ACS population, overall and according to clinical interest groups including event type (STEMI, NSTEMI, UA) and other relevant subgroups of patients.

    Between January 1st, 2012 and 31st, December 2021 (study period).

  • Incidence of heart failure after acute coronary syndrome

    The second co-primary outcome of the study is the incidence rate of HF after ACS of all patients discharged alive after an ACS in Catalonia

    Between January 1st, 2012 and 31st, December 2021 (study period).

Secondary Outcomes (2)

  • Clinical endpoints

    Between January 1st, 2012 and 31st, December 2021 (study period).

  • Healthcare resource use endpoints

    Between January 1st, 2012 and 31st, December 2021 (study period).

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Analyses will cover the entire population of Catalonia (Spain, N = 7.860.563 as of December 31st, 2020), a region in which the Catalan Health Service granted universal health coverage.

You may qualify if:

  • Admission with the primary diagnosis of acute coronary syndrome ( Non-ST-Elevation Myocardial Infarction -NSTEMI-, ST-Elevation Myocardial Infarction -STEMI-, Unestable Angina -UA-)

You may not qualify if:

  • Death before discharge from index event.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Bellvitge

L'Hospitalet de Llobregat, Barcelona, 08907, Spain

Location

MeSH Terms

Conditions

Heart FailureAcute Coronary SyndromeMyocardial Infarction

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesMyocardial IschemiaVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Innovation, Research and Universities of the South-Metropolitan Healthcare Area

Study Record Dates

First Submitted

February 4, 2024

First Posted

February 13, 2024

Study Start

January 1, 2012

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

February 16, 2024

Record last verified: 2024-02

Locations